Huirong Pan

机构：Wenzhou Medical University, Affiliated Eye Hospital of Wenzhou Medical College

发表论文 49 篇 · 总被引 1362 次 · h-index 16

代表论文

• Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial (2022 · The Lancet Infectious Diseases · 被引 93)
• Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial (2024 · The Lancet · 被引 73)
• Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response (2021 · Emerging Microbes & Infections · 被引 61)
• Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women (2019 · Science China Life Sciences · 被引 52)
• Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18–26 years in China: a randomised blinded clinical trial (2023 · The Lancet Infectious Diseases · 被引 45)
• Safety and immunogenicity of hepatitis E vaccine in elderly people older than 65 years (2019 · Vaccine · 被引 35)